Paper39809756
Digestive cancers: mechanisms, therapeutics and management.
Zhan T and 9 others. Signal Transduct Target Ther, 2025. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Digestive cancers: mechanisms, therapeutics and management. Papers, record 39809756. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39809756
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Digestive System Neoplasms | Major topic |
| Humans | |
| Immunotherapy |
Source PubMed
References543
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20728210 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. | Lancet | 2010 | https://conductscience.org/library/papers/20728210 | PubMed |
| 2 | 37731056 | Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer. | Oncogene | 2023 | https://conductscience.org/library/papers/37731056 | PubMed |
| 3 | 27907852 | The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. | Eur J Cancer | 2017 | https://conductscience.org/library/papers/27907852 | PubMed |
| 4 | 38664720 | Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38664720 | PubMed |
| 5 | 26371427 | Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization. | Appl Immunohistochem Mol Morphol | 2017 | https://conductscience.org/library/papers/26371427 | PubMed |
| 6 | 14534886 | Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. | Cancer | 2003 | https://conductscience.org/library/papers/14534886 | PubMed |
| 7 | 24185513 | Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. | Nat Genet | 2013 | https://conductscience.org/library/papers/24185513 | PubMed |
| 8 | 25712293 | HER2 expression status in diverse cancers: review of results from 37,992 patients. | Cancer Metastasis Rev | 2015 | https://conductscience.org/library/papers/25712293 | PubMed |
| 9 | 34258720 | Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival. | Ann Surg Oncol | 2021 | https://conductscience.org/library/papers/34258720 | PubMed |
| 10 | 18650514 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18650514 | PubMed |
| 11 | 30070719 | CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma. | Hepatology | 2019 | https://conductscience.org/library/papers/30070719 | PubMed |
| 12 | 37872225 | CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. | Nat Med | 2023 | https://conductscience.org/library/papers/37872225 | PubMed |
| 13 | 38871975 | Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial. | Nat Med | 2024 | https://conductscience.org/library/papers/38871975 | PubMed |
| 14 | 32152502 | Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer. | Br J Cancer | 2020 | https://conductscience.org/library/papers/32152502 | PubMed |
| 15 | 29480368 | The Global Epidemic of the Metabolic Syndrome. | Curr Hypertens Rep | 2018 | https://conductscience.org/library/papers/29480368 | PubMed |
| 16 | 26258846 | Genomic spectra of biliary tract cancer. | Nat Genet | 2015 | https://conductscience.org/library/papers/26258846 | PubMed |
| 17 | 27435280 | ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286). | BMC Cancer | 2016 | https://conductscience.org/library/papers/27435280 | PubMed |
| 18 | 17470860 | Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17470860 | PubMed |
| 19 | 27899187 | Genetic predisposition to gastric cancer. | Semin Oncol | 2016 | https://conductscience.org/library/papers/27899187 | PubMed |
| 20 | 34536299 | Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials. | Int J Cancer | 2022 | https://conductscience.org/library/papers/34536299 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42955452 | Oxeiptosis in gastrointestinal cancer: molecular mechanisms, therapeutic strategies, and future perspectives. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42955452 | PubMed |
| 42949869 | Challenges and recommendations for implementation of oncology clinical practice guidelines in China. | PLoS Med | 2026 | https://conductscience.org/library/papers/42949869 | PubMed |
| 42830923 | CPT-TCPP polymeric nanoplatform for sonodynamic-chemotherapy synergistic tumor therapy through ferroptosis-apoptosis dual cell death reprogramming. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42830923 | PubMed |
| 42773444 | Targeting the Notch signaling pathway in digestive system cancers: from bench to bedside. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42773444 | PubMed |
| 42750951 | ANP32A interacts with LDHA to modulate glycolysis and ferroptosis in hepatocellular carcinoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42750951 | PubMed |
| 42683405 | CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcinoma. | Ann Gastroenterol Surg | 2026 | https://conductscience.org/library/papers/42683405 | PubMed |
| 42661227 | Dual-energy CT extracellular volume fraction for predicting the chemotherapeutic response in pancreatic ductal adenocarcinoma. | Cancer Imaging | 2026 | https://conductscience.org/library/papers/42661227 | PubMed |
| 42649986 | Biological and Targeted Therapies in the Multidisciplinary Management of Gastrointestinal Cancers. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649986 | PubMed |
| 42624930 | Pharmacological inhibition of CDK7 and CDK9 suppresses gastrointestinal (colon) cancer progression through modulation of stemness, epithelial-mesenchymal transition, and chemoresistance. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42624930 | PubMed |
| 42597867 | LncRNA FAM66C enhances gastric cancer proliferation and chemoresistance through phosphorylating nuclear YAP protein. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42597867 | PubMed |
| 42516142 | Trends in liver failure-related mortality among middle-aged and older adults with digestive system malignant tumors in the United States, 1999-2023. | Front Oncol | 2026 | https://conductscience.org/library/papers/42516142 | PubMed |
| 42458480 | Harnessing tumor-associated exosomal aminopeptidase N as a dual-function tool for monitoring and tackling chemoresistance in gastric cancer. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42458480 | PubMed |
| 42415117 | Targeting HASPIN-mediated H3T3 phosphorylation disrupts an epigenetic-kinesin axis to suppress colorectal cancer mitotic progression. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42415117 | PubMed |
| 42357585 | Plant-Derived Foods and Medicines as Modulators of the Gut Microbiome: Molecular Interactions and Implications for Disease and Therapy. | Molecules | 2026 | https://conductscience.org/library/papers/42357585 | PubMed |
| 42352257 | Aloperine Suppresses the Tumorigenicity of Esophageal Squamous Cell Carcinoma by Targeting the AP-1/IL-6/STAT3 Signaling Axis. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352257 | PubMed |
| 42327781 | CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42327781 | PubMed |
| 42323891 | Significance of Positive Cerebrospinal Fluid Cytology (Leptomeningeal Metastasis) in Central Nervous System Metastasis - A Multicentre Clinicopathological Review. | Pathol Int | 2026 | https://conductscience.org/library/papers/42323891 | PubMed |
| 42305470 | Predictive modelling of duodenal stump leakage after gastric cancer and long-term oncological outcomes. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42305470 | PubMed |
| 42298691 | Analysis and validation of abnormal signaling pathways and immune cell infiltration characteristics in digestive system cancers based on peroxisome-related genes. | Biol Direct | 2026 | https://conductscience.org/library/papers/42298691 | PubMed |
| 42278660 | Novel Disease-Specific Panel of Salivary microRNAs for the Detection of Oral Squamous Cell Carcinoma from Early Invasion to Stage IV Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278660 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39809756
GET https://conductscience.org/api/papers/v1/39809756/references?page=2